风湿性关节炎-话题@MedSci

#风湿性关节炎#

429篇内容 | 6935人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1483603, encodeId=a26a1483603c6, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Ann Rheum Dis：Janus激酶抑制剂对类风湿性关节炎患者心血管事件风险的影响, objectType=article, longId=166417, objectId=58c816641e1e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58c816641e1e, replyNumber=0, likeNumber=63, createdTime=2019-05-22, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58c816641e1e, moduleTitle=Ann Rheum Dis：Janus激酶抑制剂对类风湿性关节炎患者心血管事件风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58c816641e1e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483602, encodeId=1bda14836029f, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Ann Rheum Dis：与类风湿性关节炎患者骨折风险相关的药物, objectType=article, longId=166412, objectId=1caf16641281, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1caf16641281, replyNumber=0, likeNumber=79, createdTime=2019-05-22, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1caf16641281, moduleTitle=Ann Rheum Dis：与类风湿性关节炎患者骨折风险相关的药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1caf16641281)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483601, encodeId=f7d3148360127, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=【盘点】类风湿性关节炎近期重要研究一览, objectType=article, longId=166346, objectId=43bb166346bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43bb166346bd, replyNumber=0, likeNumber=65, createdTime=2019-05-20, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43bb166346bd, moduleTitle=【盘点】类风湿性关节炎近期重要研究一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43bb166346bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483600, encodeId=dbbb14836000c, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Arthritis Rheumatol：与强直性脊柱炎和类风湿性关节炎风险相关的HLA等位基因影响肠道微生物组, objectType=article, longId=165385, objectId=a94916538593, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a94916538593, replyNumber=0, likeNumber=39, createdTime=2019-05-06, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a94916538593, moduleTitle=Arthritis Rheumatol：与强直性脊柱炎和类风湿性关节炎风险相关的HLA等位基因影响肠道微生物组, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a94916538593)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483599, encodeId=e7ea1483599b3, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎患者从阿达木单抗改为巴瑞替尼治疗的临床结局, objectType=article, longId=165369, objectId=634316536912, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=634316536912, replyNumber=0, likeNumber=98, createdTime=2019-05-06, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=634316536912, moduleTitle=Ann Rheum Dis：类风湿性关节炎患者从阿达木单抗改为巴瑞替尼治疗的临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=634316536912)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483598, encodeId=f447148359801, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Clin Exp Rheumatol：赛妥珠单抗治疗类风湿性关节炎的疗效和安全性, objectType=article, longId=165130, objectId=fbbc16513063, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbbc16513063, replyNumber=0, likeNumber=73, createdTime=2019-04-30, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbbc16513063, moduleTitle=Clin Exp Rheumatol：赛妥珠单抗治疗类风湿性关节炎的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbbc16513063)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483597, encodeId=204a148359e04, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=J Rheumatol：抗CCP3.1和抗CCP-IgA与无类风湿性关节炎个体的年龄增加相关, objectType=article, longId=165035, objectId=1cad16503571, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cad16503571, replyNumber=0, likeNumber=65, createdTime=2019-04-28, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cad16503571, moduleTitle=J Rheumatol：抗CCP3.1和抗CCP-IgA与无类风湿性关节炎个体的年龄增加相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cad16503571)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483596, encodeId=6be1148359637, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Semin Arthritis Rheu：伴COPD的类风湿性关节炎患者中阿巴西普的安全性, objectType=article, longId=164934, objectId=e1eb1649348a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1eb1649348a, replyNumber=0, likeNumber=88, createdTime=2019-04-26, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1eb1649348a, moduleTitle=Semin Arthritis Rheu：伴COPD的类风湿性关节炎患者中阿巴西普的安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1eb1649348a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483595, encodeId=909b1483595ca, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Semin Arthritis Rheu：类风湿性关节炎女性患者的产科结局, objectType=article, longId=164933, objectId=b6f716493307, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6f716493307, replyNumber=0, likeNumber=65, createdTime=2019-04-26, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6f716493307, moduleTitle=Semin Arthritis Rheu：类风湿性关节炎女性患者的产科结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6f716493307)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483594, encodeId=743c1483594d7, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Semin Arthritis Rheu：老年类风湿性关节炎患者使用生物制剂的疗效和安全性, objectType=article, longId=164931, objectId=89191649313a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89191649313a, replyNumber=0, likeNumber=62, createdTime=2019-04-26, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89191649313a, moduleTitle=Semin Arthritis Rheu：老年类风湿性关节炎患者使用生物制剂的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89191649313a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483593, encodeId=d9dd148359356, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Arthritis Rheumatol：阿托伐他汀用于类风湿性关节炎心血管事件的一级预防, objectType=article, longId=164828, objectId=56a3164828d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56a3164828d3, replyNumber=0, likeNumber=57, createdTime=2019-04-24, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56a3164828d3, moduleTitle=Arthritis Rheumatol：阿托伐他汀用于类风湿性关节炎心血管事件的一级预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56a3164828d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483592, encodeId=bb74148359287, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Arthritis Rheumatol：类风湿性关节炎疾病活动性预测偶发性RA相关间质性肺病, objectType=article, longId=163841, objectId=983b163841b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=983b163841b5, replyNumber=0, likeNumber=55, createdTime=2019-04-10, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=983b163841b5, moduleTitle=Arthritis Rheumatol：类风湿性关节炎疾病活动性预测偶发性RA相关间质性肺病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=983b163841b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483591, encodeId=48711483591a8, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Arthritis Rheumatol：类风湿性关节炎临床缓解期间应当减少还是维持皮下托珠单抗的剂量？, objectType=article, longId=163834, objectId=76c3163834db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76c3163834db, replyNumber=0, likeNumber=88, createdTime=2019-04-10, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76c3163834db, moduleTitle=Arthritis Rheumatol：类风湿性关节炎临床缓解期间应当减少还是维持皮下托珠单抗的剂量？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76c3163834db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483590, encodeId=d31d14835906c, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎患者疾病控制后逐渐减少TNF抑制剂与常规合成DMARDs的比较, objectType=article, longId=163822, objectId=8ea416382257, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ea416382257, replyNumber=0, likeNumber=59, createdTime=2019-04-10, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ea416382257, moduleTitle=Ann Rheum Dis：类风湿性关节炎患者疾病控制后逐渐减少TNF抑制剂与常规合成DMARDs的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ea416382257)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483589, encodeId=43bd148358972, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Arthritis Rheumatol：女性体力活动与随后的类风湿性关节炎风险, objectType=article, longId=163493, objectId=ea06163493eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea06163493eb, replyNumber=0, likeNumber=66, createdTime=2019-04-04, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea06163493eb, moduleTitle=Arthritis Rheumatol：女性体力活动与随后的类风湿性关节炎风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea06163493eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483588, encodeId=314a148358847, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Arthritis Rheumatol：骨关节炎疾病负担类似于初次就诊的类风湿性关节炎，并在6个月后显著变大, objectType=article, longId=163012, objectId=73d5163012e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73d5163012e9, replyNumber=0, likeNumber=64, createdTime=2019-03-28, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73d5163012e9, moduleTitle=Arthritis Rheumatol：骨关节炎疾病负担类似于初次就诊的类风湿性关节炎，并在6个月后显著变大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73d5163012e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483587, encodeId=9d48148358e97, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Ann Rheum Dis：BI 655064对活动性类风湿性关节炎临床和生物标志物参数的影响, objectType=article, longId=162862, objectId=9bb21628622a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bb21628622a, replyNumber=0, likeNumber=56, createdTime=2019-03-26, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bb21628622a, moduleTitle=Ann Rheum Dis：BI 655064对活动性类风湿性关节炎临床和生物标志物参数的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bb21628622a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483586, encodeId=406114835863f, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=高剂量托法替尼治疗类风湿性关节炎可增加肺部血栓的风险, objectType=article, longId=162737, objectId=d920162e37ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d920162e37ad, replyNumber=0, likeNumber=68, createdTime=2019-03-23, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d920162e37ad, moduleTitle=高剂量托法替尼治疗类风湿性关节炎可增加肺部血栓的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d920162e37ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483585, encodeId=24261483585eb, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Semin Arthritis Rheu：与类风湿性关节炎患者使用托珠单抗vs其他生物制剂相关的恶性肿瘤风险, objectType=article, longId=162333, objectId=0fa216233337, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fa216233337, replyNumber=0, likeNumber=64, createdTime=2019-03-16, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fa216233337, moduleTitle=Semin Arthritis Rheu：与类风湿性关节炎患者使用托珠单抗vs其他生物制剂相关的恶性肿瘤风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fa216233337)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483584, encodeId=27db1483584bb, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=2018 APLAR建议：类风湿性关节炎的治疗（更新版）, objectType=article, longId=162268, objectId=19121622681d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19121622681d, replyNumber=0, likeNumber=14, createdTime=2019-03-14, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19121622681d, moduleTitle=2018 APLAR建议：类风湿性关节炎的治疗（更新版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19121622681d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

风湿性关节炎

2020-05-29发表于威斯康星

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Ann Rheum Dis：Janus激酶抑制剂对类风湿性关节炎患者心血管事件风险的影响

2019-05-22

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Ann Rheum Dis：与类风湿性关节炎患者骨折风险相关的药物

2019-05-22

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

【盘点】类风湿性关节炎近期重要研究一览

2019-05-20

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Arthritis Rheumatol：与强直性脊柱炎和类风湿性关节炎风险相关的HLA等位基因影响肠道微生物组

2019-05-06

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Ann Rheum Dis：类风湿性关节炎患者从阿达木单抗改为巴瑞替尼治疗的临床结局

2019-05-06

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Clin Exp Rheumatol：赛妥珠单抗治疗类风湿性关节炎的疗效和安全性

2019-04-30

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

J Rheumatol：抗CCP3.1和抗CCP-IgA与无类风湿性关节炎个体的年龄增加相关

2019-04-28

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Semin Arthritis Rheu：伴COPD的类风湿性关节炎患者中阿巴西普的安全性

2019-04-26

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Semin Arthritis Rheu：类风湿性关节炎女性患者的产科结局

2019-04-26

智智灵药 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Semin Arthritis Rheu：老年类风湿性关节炎患者使用生物制剂的疗效和安全性

2019-04-26

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Arthritis Rheumatol：阿托伐他汀用于类风湿性关节炎心血管事件的一级预防

2019-04-24

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Arthritis Rheumatol：类风湿性关节炎疾病活动性预测偶发性RA相关间质性肺病

2019-04-10

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Arthritis Rheumatol：类风湿性关节炎临床缓解期间应当减少还是维持皮下托珠单抗的剂量？

2019-04-10

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Ann Rheum Dis：类风湿性关节炎患者疾病控制后逐渐减少TNF抑制剂与常规合成DMARDs的比较

2019-04-10

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Arthritis Rheumatol：女性体力活动与随后的类风湿性关节炎风险

2019-04-04

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Arthritis Rheumatol：骨关节炎疾病负担类似于初次就诊的类风湿性关节炎，并在6个月后显著变大

2019-03-28

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Ann Rheum Dis：BI 655064对活动性类风湿性关节炎临床和生物标志物参数的影响

2019-03-26

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

高剂量托法替尼治疗类风湿性关节炎可增加肺部血栓的风险

2019-03-23

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Semin Arthritis Rheu：与类风湿性关节炎患者使用托珠单抗vs其他生物制剂相关的恶性肿瘤风险

2019-03-16

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

2018 APLAR建议：类风湿性关节炎的治疗（更新版）

2019-03-14

科室
- - 订阅+
  - 更多科室
工具
服务